US Stock MarketDetailed Quotes

vTv Therapeutics (VTVT)

Watchlist
  • 32.315
  • +0.515+1.62%
Trading May 6 10:00 ET
127.28MMarket Cap-10.10P/E (TTM)

vTv Therapeutics (VTVT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0.21%-25.26M
-91.73%-9.25M
18.64%-5.22M
24.28%-5.1M
22.47%-5.69M
-32.63%-25.31M
-65.58%-4.83M
-32.77%-6.42M
-9.11%-6.73M
-41.99%-7.34M
Net income from continuing operations
-36.89%-31.08M
-60.87%-7.14M
-77.14%-10.35M
-15.15%-7.38M
-3.29%-6.22M
12.56%-22.71M
0.09%-4.44M
31.62%-5.84M
11.12%-6.41M
-4.24%-6.02M
Operating gains losses
1,520.00%142K
573.08%123K
124.69%40K
65.80%-66K
-87.87%45K
99.72%-10K
99.19%-26K
52.49%-162K
36.30%-193K
55.88%371K
Depreciation and amortization
-82.02%16K
-90.91%2K
-90.91%2K
-86.96%3K
-59.09%9K
-1.11%89K
-4.35%22K
0.00%22K
0.00%23K
0.00%22K
Change In working capital
134.79%1.89M
-169.89%-3.26M
415.57%4.07M
240.54%1.42M
82.53%-337K
-223.76%-5.44M
-194.01%-1.21M
-2,589.58%-1.29M
-180.08%-1.01M
-201.74%-1.93M
-Change in receivables
----
----
----
----
----
-43.66%40K
276.47%180K
--64K
--675K
-608.09%-879K
-Change in prepaid assets
307.87%449K
153.01%97K
38.57%-481K
11.34%383K
10.84%450K
-113.93%-216K
-120.65%-183K
-42.88%-783K
-34.10%344K
-41.24%406K
-Change in payables and accrued expense
129.34%1.53M
-170.73%-3.25M
911.86%4.59M
152.84%1.03M
44.67%-836K
-278.05%-5.22M
-281.94%-1.2M
-213.00%-565K
-362.87%-1.94M
-246.41%-1.51M
-Change in other current assets
-54.19%82K
-135.04%-82K
-85.00%15K
-91.10%56K
111.86%93K
163.24%179K
244.12%234K
--100K
--629K
---784K
-Change in other current liabilities
0.00%-169K
27.27%-32K
-9.30%-47K
-9.52%-46K
-10.00%-44K
-9.74%-169K
71.43%-44K
---43K
---42K
---40K
-Change in other working capital
----
----
----
----
----
---17K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
0.21%-25.26M
-91.73%-9.25M
18.64%-5.22M
24.28%-5.1M
22.47%-5.69M
-32.63%-25.31M
-65.58%-4.83M
-32.77%-6.42M
-9.11%-6.73M
-41.99%-7.34M
Investing cash flow
Cash flow from continuing investing activities
0
0
Net PPE purchase and sale
----
----
----
----
----
--0
----
----
----
----
Net business purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
----
----
----
----
--0
----
----
----
----
Financing cash flow
Cash flow from continuing financing activities
47.21%77.44M
-321K
3,058.91%77.8M
-42K
0
338.50%52.61M
0
420.72%2.46M
0
324.73%50.14M
Net issuance payments of debt
--0
---328K
--328K
--0
--0
-478.79%-191K
--0
--0
--0
-101.62%-191K
Net common stock issuance
46.74%77.48M
--0
3,045.59%77.48M
--0
--0
338.89%52.8M
--0
--2.46M
--0
--50.34M
Proceeds from stock option exercised by employees
--16K
--7K
--0
----
----
--0
--0
--0
----
----
Net other financing activities
---51K
--0
--0
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
47.21%77.44M
---321K
3,058.91%77.8M
---42K
--0
338.50%52.61M
--0
420.72%2.46M
--0
324.73%50.14M
Net cash flow
Beginning cash position
289.01%36.75M
136.95%98.5M
-43.06%25.92M
-40.56%31.06M
289.01%36.75M
-22.10%9.45M
404.62%41.57M
261.35%45.53M
178.46%52.26M
-22.10%9.45M
Current changes in cash
91.16%52.19M
-98.38%-9.57M
1,935.20%72.58M
23.66%-5.14M
-113.28%-5.69M
1,118.66%27.3M
-499.42%-4.83M
9.31%-3.96M
-9.11%-6.73M
544.71%42.81M
End cash Position
142.02%88.93M
142.02%88.93M
136.95%98.5M
-43.06%25.92M
-40.56%31.06M
289.01%36.75M
289.01%36.75M
404.62%41.57M
261.35%45.53M
178.46%52.26M
Free cash flow
0.21%-25.26M
-91.73%-9.25M
18.64%-5.22M
24.28%-5.1M
22.47%-5.69M
-32.63%-25.31M
-65.58%-4.83M
-32.77%-6.42M
-9.11%-6.73M
-41.99%-7.34M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0.21%-25.26M-91.73%-9.25M18.64%-5.22M24.28%-5.1M22.47%-5.69M-32.63%-25.31M-65.58%-4.83M-32.77%-6.42M-9.11%-6.73M-41.99%-7.34M
Net income from continuing operations -36.89%-31.08M-60.87%-7.14M-77.14%-10.35M-15.15%-7.38M-3.29%-6.22M12.56%-22.71M0.09%-4.44M31.62%-5.84M11.12%-6.41M-4.24%-6.02M
Operating gains losses 1,520.00%142K573.08%123K124.69%40K65.80%-66K-87.87%45K99.72%-10K99.19%-26K52.49%-162K36.30%-193K55.88%371K
Depreciation and amortization -82.02%16K-90.91%2K-90.91%2K-86.96%3K-59.09%9K-1.11%89K-4.35%22K0.00%22K0.00%23K0.00%22K
Change In working capital 134.79%1.89M-169.89%-3.26M415.57%4.07M240.54%1.42M82.53%-337K-223.76%-5.44M-194.01%-1.21M-2,589.58%-1.29M-180.08%-1.01M-201.74%-1.93M
-Change in receivables ---------------------43.66%40K276.47%180K--64K--675K-608.09%-879K
-Change in prepaid assets 307.87%449K153.01%97K38.57%-481K11.34%383K10.84%450K-113.93%-216K-120.65%-183K-42.88%-783K-34.10%344K-41.24%406K
-Change in payables and accrued expense 129.34%1.53M-170.73%-3.25M911.86%4.59M152.84%1.03M44.67%-836K-278.05%-5.22M-281.94%-1.2M-213.00%-565K-362.87%-1.94M-246.41%-1.51M
-Change in other current assets -54.19%82K-135.04%-82K-85.00%15K-91.10%56K111.86%93K163.24%179K244.12%234K--100K--629K---784K
-Change in other current liabilities 0.00%-169K27.27%-32K-9.30%-47K-9.52%-46K-10.00%-44K-9.74%-169K71.43%-44K---43K---42K---40K
-Change in other working capital -----------------------17K----------------
Cash from discontinued investing activities
Operating cash flow 0.21%-25.26M-91.73%-9.25M18.64%-5.22M24.28%-5.1M22.47%-5.69M-32.63%-25.31M-65.58%-4.83M-32.77%-6.42M-9.11%-6.73M-41.99%-7.34M
Investing cash flow
Cash flow from continuing investing activities 00
Net PPE purchase and sale ----------------------0----------------
Net business purchase and sale --0------------------0----------------
Cash from discontinued investing activities
Investing cash flow --0------------------0----------------
Financing cash flow
Cash flow from continuing financing activities 47.21%77.44M-321K3,058.91%77.8M-42K0338.50%52.61M0420.72%2.46M0324.73%50.14M
Net issuance payments of debt --0---328K--328K--0--0-478.79%-191K--0--0--0-101.62%-191K
Net common stock issuance 46.74%77.48M--03,045.59%77.48M--0--0338.89%52.8M--0--2.46M--0--50.34M
Proceeds from stock option exercised by employees --16K--7K--0----------0--0--0--------
Net other financing activities ---51K--0--0----------------------------
Cash from discontinued financing activities
Financing cash flow 47.21%77.44M---321K3,058.91%77.8M---42K--0338.50%52.61M--0420.72%2.46M--0324.73%50.14M
Net cash flow
Beginning cash position 289.01%36.75M136.95%98.5M-43.06%25.92M-40.56%31.06M289.01%36.75M-22.10%9.45M404.62%41.57M261.35%45.53M178.46%52.26M-22.10%9.45M
Current changes in cash 91.16%52.19M-98.38%-9.57M1,935.20%72.58M23.66%-5.14M-113.28%-5.69M1,118.66%27.3M-499.42%-4.83M9.31%-3.96M-9.11%-6.73M544.71%42.81M
End cash Position 142.02%88.93M142.02%88.93M136.95%98.5M-43.06%25.92M-40.56%31.06M289.01%36.75M289.01%36.75M404.62%41.57M261.35%45.53M178.46%52.26M
Free cash flow 0.21%-25.26M-91.73%-9.25M18.64%-5.22M24.28%-5.1M22.47%-5.69M-32.63%-25.31M-65.58%-4.83M-32.77%-6.42M-9.11%-6.73M-41.99%-7.34M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report by AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has bee Show More